Health
Trump-touted hydroxychloroquine shows no benefit in COVID-19 prevention: Study – The Jakarta Post – Jakarta Post
A malaria drug taken by US President Donald Trump to prevent COVID-19 did not show any benefit versus placebo in reducing coronavirus infection among healthcare…
A malaria drug taken by US President Donald Trump to prevent COVID-19 did not show any benefit versus placebo in reducing coronavirus infection among healthcare workers, according to clinical trial results published on Wednesday.
The study largely confirms results from a clinical trial in June that showed hydroxychloroquine was ineffective in preventing infection among people exposed to the new coronavirus.
Trump began backing hydroxychloroquine early in the pandemic and told reporters in May …
-
Noosa News18 hours agoWoman was watching keepers work when lion attacked, Darling Downs Zoo says
-
Noosa News16 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
General20 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
Noosa News23 hours agoTips to improve engagement – Proctor